Literature DB >> 8855191

Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development.

B Gil1, M Casado, M A Pajares, L Boscá, J M Mato, P Martín-Sanz, L Alvarez.   

Abstract

The pattern of expression of liver-specific and extrahepatic S-adenosylmethionine (SAM) synthetase in developing rat liver was established by determining steady-state levels of the respective messenger RNAs (mRNAs) and protein content. Levels of liver-specific SAM synthetase mRNA increased progressively from day 20 of gestation, increased 10-fold immediately after birth, and reached a peak at 10 days of age, decreasing slightly by adulthood. Conversely, mRNA levels of extrahepatic isoenzyme decreased toward birth, increased threefold in the newborn, and decreased further in the postnatal life, reaching a minimum in the adult. Similar expression profiles were observed in isolated hepatocytes, indicating that both mRNAs are differentially regulated in the same cell type. Western blot analysis showed that levels of immunoreactive liver-specific isoenzyme followed a trend similar to the mRNA, indicating that developmental regulation of this enzyme is mediated at the mRNA level. Developmental patterns of expression of albumin and alpha-fetoprotein (AFP) mRNAs were closely related to those for liver-specific and extrahepatic isoenzymes, respectively. Therefore, it is suggested that liver-specific SAM synthetase may be a marker for hepatocyte differentiation. Incubation of primary cultures of hepatocytes from 21-day-old fetuses with permeant cyclic adenosine monophosphate (cAMP) analogues elicited an up-regulation of the mRNA for the liver-specific isoenzyme with a concomitant down-regulation of the extrahepatic message, suggesting a physiological role for the increased postnatal glucagonemia in the control of this isoenzyme switching. In contrast with the isoenzyme expression profiles, the levels of SAM, the product of SAM synthetase reaction, were determined to be greater during gestation than in immediate postnatal periods. These results indicate that synthesis and utilization of SAM may be regulated differentially in fetal and adult hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855191     DOI: 10.1002/hep.510240420

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

1.  Proteomic analysis of human hepatoma cells expressing methionine adenosyltransferase I/III: Characterization of DDX3X as a target of S-adenosylmethionine.

Authors:  Paul C Schröder; Joaquín Fernández-Irigoyen; Emilie Bigaud; Antonio Serna; Rubén Renández-Alcoceba; Shelly C Lu; José M Mato; Jesús Prieto; Fernando J Corrales
Journal:  J Proteomics       Date:  2012-01-16       Impact factor: 4.044

2.  Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation.

Authors:  S C Lu; L Alvarez; Z Z Huang; L Chen; W An; F J Corrales; M A Avila; G Kanel; J M Mato
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  S-Adenosylmethionine regulates connexins sub-types expressed by hepatocytes.

Authors:  Sachie Yamaji; Anna Droggiti; Shelly C Lu; Maria L Martinez-Chantar; Anne Warner; Marta Varela-Rey
Journal:  Eur J Cell Biol       Date:  2010-11-18       Impact factor: 4.492

4.  Acute liver injury induces nucleocytoplasmic redistribution of hepatic methionine metabolism enzymes.

Authors:  Miguel Delgado; Francisco Garrido; Juliana Pérez-Miguelsanz; María Pacheco; Teresa Partearroyo; Dolores Pérez-Sala; María Angeles Pajares
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

5.  Inhibition of human methionine adenosyltransferase 1A transcription by coding region methylation.

Authors:  Maria Lauda Tomasi; Tony W H Li; Mei Li; José M Mato; Shelly C Lu
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

6.  Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation.

Authors:  Yuan Ji; Kendra K S Nordgren; Yubo Chai; Scott J Hebbring; Gregory D Jenkins; Ryan P Abo; Yi Peng; Linda L Pelleymounter; Irene Moon; Bruce W Eckloff; Xiaoshan Chai; Jianping Zhang; Brooke L Fridley; Vivien C Yee; Eric D Wieben; Richard M Weinshilboum
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

7.  Expression of folate pathway genes in the cartilage of Hoxd4 and Hoxc8 transgenic mice.

Authors:  Claudia Kruger; Catherine Talmadge; Claudia Kappen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-04

Review 8.  The logic of the hepatic methionine metabolic cycle.

Authors:  M V Martinov; V M Vitvitsky; R Banerjee; F I Ataullakhanov
Journal:  Biochim Biophys Acta       Date:  2009-10-13

Review 9.  S-adenosylmethionine in liver health, injury, and cancer.

Authors:  Shelly C Lu; José M Mato
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

10.  Lentivirus mediated shRNA interference targeting MAT2B induces growth-inhibition and apoptosis in hepatocelluar carcinoma.

Authors:  Qun Wang; Quan-Yan Liu; Zhi-Su Liu; Qun Qian; Quan Sun; Ding-Yu Pan
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.